Oct 30 (Reuters) - AbbVie ( ABBV ) raised its annual profit forecast on Wednesday after strong sales of its newer immunology drugs and key cancer treatment helped the company beat Wall Street estimates for third-quarter earnings. The company now expects its full-year adjusted profit to be between $10.90 and $10.94 per share, compared with its prior forecast range of...

07:34 AM EDT, 10/30/2024 (MT Newswires) -- AerCap Holdings NV ( AER ) reported Q3 earnings Wednesday of $1.95 per diluted share, down from $4.86 a year earlier. Three analysts polled by Capital IQ expected $2.19 per share. Revenue for the quarter ended Sept. 30 was $1.95 billion, up from $1.89 billion a year earlier. Four analysts polled by Capital...

07:39 AM EDT, 10/30/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) reported a Q3 adjusted loss Wednesday of $0.05 per diluted share, wider than the loss of $0.03 a year earlier. Analysts polled by Capital IQ expected a loss of $0.05. Total operating expenses for the quarter ended Sept. 30 were $58.1 million, up from $20.7 million a year...

07:39 AM EDT, 10/30/2024 (MT Newswires) -- KKR & Co. ( KKR ) and Energy Capital Partners said Wednesday they have formed a $50 billion partnership to accelerate data center, power generation and transmission infrastructure development. The collaboration aims to develop the infrastructure necessary for the rapid expansion of artificial intelligence and cloud computing globally, the companies said. Price: 139.85,...